Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marian C Bryan

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Journal of the American Chemical Society|April 28, 2026
Direct Access to Iron Carbenes from Aldehyde, Ketone, and Formamide FeedstocksP Scott Pedersen, Katherine I Burton, Sven H M Kaster, et al.
Journal of the American Chemical Society|July 15, 2004
Covalent display of oligosaccharide arrays in microtiter platesMarian C Bryan, Fabio Fazio, Hing-Ken Lee, et al.
Journal of Medicinal Chemistry|December 12, 2024
Toward Dose Prediction at Point of DesignDries Van Rompaey, Siladitya Ray Chaudhuri, Mazen Ahmad, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2015
4-Aminoindazolyl-dihydrofuro[3,4-d]pyrimidines as non-covalent inhibitors of mutant epidermal growth factor receptor tyrosine kinaseEmily J Hanan, Matt Baumgardner, Marian C Bryan, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 2004
Printed covalent glycan array for ligand profiling of diverse glycan binding proteinsOla Blixt, Steve Head, Tony Mondala, et al.
Journal of Medicinal Chemistry|November 13, 2014
Lead optimization and modulation of hERG activity in a series of aminooxazoline xanthene β-site amyloid precursor protein cleaving enzyme (BACE1) inhibitorsOleg Epstein, Marian C Bryan, Alan C Cheng, et al.
Journal of Medicinal Chemistry|May 27, 2011
Phospshoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors: discovery and structure-activity relationships of a series of quinoline and quinoxaline derivativesNobuko Nishimura, Aaron Siegmund, Longbin Liu, et al.
ACS Medicinal Chemistry Letters|January 29, 2016
Pyridones as Highly Selective, Noncovalent Inhibitors of T790M Double Mutants of EGFRMarian C Bryan, Daniel J Burdick, Bryan K Chan, et al.
ACS Medicinal Chemistry Letters|March 19, 2020
Discovery of Potent Benzolactam IRAK4 Inhibitors with Robust in Vivo ActivityNaomi S Rajapaksa, Alberto Gobbi, Joy Drobnick, et al.
Journal of Medicinal Chemistry|May 15, 2019
Development of Potent and Selective Pyrazolopyrimidine IRAK4 InhibitorsMarian C Bryan, Joy Drobnick, Alberto Gobbi, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Journal of the American Chemical Society|April 28, 2026
Direct Access to Iron Carbenes from Aldehyde, Ketone, and Formamide FeedstocksP Scott Pedersen, Katherine I Burton, Sven H M Kaster, et al.
Journal of the American Chemical Society|July 15, 2004
Covalent display of oligosaccharide arrays in microtiter platesMarian C Bryan, Fabio Fazio, Hing-Ken Lee, et al.
Journal of Medicinal Chemistry|December 12, 2024
Toward Dose Prediction at Point of DesignDries Van Rompaey, Siladitya Ray Chaudhuri, Mazen Ahmad, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2015
4-Aminoindazolyl-dihydrofuro[3,4-d]pyrimidines as non-covalent inhibitors of mutant epidermal growth factor receptor tyrosine kinaseEmily J Hanan, Matt Baumgardner, Marian C Bryan, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 2004
Printed covalent glycan array for ligand profiling of diverse glycan binding proteinsOla Blixt, Steve Head, Tony Mondala, et al.
Journal of Medicinal Chemistry|November 13, 2014
Lead optimization and modulation of hERG activity in a series of aminooxazoline xanthene β-site amyloid precursor protein cleaving enzyme (BACE1) inhibitorsOleg Epstein, Marian C Bryan, Alan C Cheng, et al.
Journal of Medicinal Chemistry|May 27, 2011
Phospshoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors: discovery and structure-activity relationships of a series of quinoline and quinoxaline derivativesNobuko Nishimura, Aaron Siegmund, Longbin Liu, et al.
ACS Medicinal Chemistry Letters|January 29, 2016
Pyridones as Highly Selective, Noncovalent Inhibitors of T790M Double Mutants of EGFRMarian C Bryan, Daniel J Burdick, Bryan K Chan, et al.
ACS Medicinal Chemistry Letters|March 19, 2020
Discovery of Potent Benzolactam IRAK4 Inhibitors with Robust in Vivo ActivityNaomi S Rajapaksa, Alberto Gobbi, Joy Drobnick, et al.
Journal of Medicinal Chemistry|May 15, 2019
Development of Potent and Selective Pyrazolopyrimidine IRAK4 InhibitorsMarian C Bryan, Joy Drobnick, Alberto Gobbi, et al.
Pageof 4